{
    "2020-12-02": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|周报】把握中国优势，就是把握明年行情",
                "features": {
                    "keywords": [
                        "中国优势",
                        "行情"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】如何选股？创新赋能、制造升级和降本增效",
                "features": {
                    "keywords": [
                        "选股",
                        "创新赋能",
                        "制造升级",
                        "降本增效"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大消费行业2021年年度策略：消费复苏 渠道变革",
                "features": {
                    "keywords": [
                        "大消费",
                        "消费复苏",
                        "渠道变革"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】国家医保谈判在即，创新产业链依然值得关注——医药行业周报——中性",
                "features": {
                    "keywords": [
                        "国家医保",
                        "谈判",
                        "创新产业链"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "新冠疫苗重症预防效率达100%！4000亿巨头4天狂涨70%",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "重症预防",
                        "效率",
                        "4000亿巨头",
                        "涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【山证医药】医药行业周报（20201130）：板块估值逐步回归合理区间，建议持续关注国产创新",
                "features": {
                    "keywords": [
                        "医药行业",
                        "板块估值",
                        "国产创新"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}